Citrus Fruits Intake and Prostate Cancer Risk: A Quantitative Systematic Review

  • Bae, Jong-Myon (Department of Preventive Medicine, Cheju National University College of Medicine) ;
  • Lee, Eun-Ja (Department of Radiology, Myongji Hospital, Kwandong University, College of Medicine) ;
  • Guyatt, Gordon (CLARITY Research Group, Department of Clinical Epidemiology & Biostatistics, Health Sciences Centre, McMaster University)
  • Published : 2008.05.31

Abstract

Objectives : The purpose of this systematic review was to investigate the association between dietary intake of citrus fruits and prostate cancer risk. Methods : Authors searched electronic databases and the reference lists of publications of diet and prostate cancer studies until August 2007. All of the epidemiological studies that obtained individual data on dietary intake of citrus fruits and presented risk estimates of the association between intake of citrus fruits and risk of prostate cancer were identified and included. Using general variance-based methods, study-specific odds ratios (OR)/ relative risk (RR) and associated confidence interval (CI)/ standard error (SE) for highest versus lowest intake of citrus fruits level were extracted from each paper. Results : Eleven articles including six case-control studies, one nested case-control study and four cohort studies, proved eligible. Overall summary OR using random effect model did not show an association in risk of prostate caner with intake of citrus fruits (summary OR=1.03, 95% CI=0.89-1.19) with large heterogeneity across studies that we were unable to explain ($I^2$=67.88%). The summary ORs in case-control studies and cohort studies were 1.10 (95% CI=0.97-1.22) and 1.05 (95% CI=0.96-1.14), respectively. Conclusions : Pooled results from observational studies did not show an association between intake of citrus fruits and the risk of prostate cancer, although results vary substantially across studies.

Keywords

References

  1. American Cancer Society. Cancer Facts and Futures 2005. Atlanta: American Cancer Society; 2005
  2. Korea Central Cancer Registry. Cancer Registry and Statistics. Goyang: National Cancer Center; 2000-2005. [cited 2008 Mar 20]. Available from: URL:http://ncc.re.kr/english/infor/regi.jsp
  3. Hsing AW, Devesa SS. Trends and patterns of prostate cancer: What do they suggest? Epidemiol Rev 2001; 23(1): 3-13 https://doi.org/10.1093/oxfordjournals.epirev.a000792
  4. Pohar KS, Gong MC, Bahnson R, Miller EC, Clinton SK. Tomatoes, lycopene and prostate cancer: A clinicianUs guide for counseling those at risk for prostate cancer. World J Urol 2003; 21(1): 9-14
  5. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007; 121(7): 1571-1578 https://doi.org/10.1002/ijc.22788
  6. Clinton SK, Giovannucci E. Diet, nutrition, and prostate cancer. Annu Rev Nutr 1998; 18: 413-440 https://doi.org/10.1146/annurev.nutr.18.1.413
  7. Chan JM, Giovannucci EL. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev 2001; 23(1): 82-86 https://doi.org/10.1093/oxfordjournals.epirev.a000799
  8. Gonzalez CA. Nutrition and cancer: The current epidemiological evidence. Br J Nutr 2006; 96(Supp 1): S42-S45 https://doi.org/10.1079/BJN20061699
  9. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol 2005; 23(32): 8152-8160 https://doi.org/10.1200/JCO.2005.03.1492
  10. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Cancer Epidemiol Biomarkers Prev2007; 16(7): 1364-1370
  11. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274(2): 532-538 https://doi.org/10.1016/0003-9861(89)90467-0
  12. Cook NR, Stampfer MJ, Ma J, Manson JE, Sacks FM, Burning JE, et al. $\beta$-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 1999; 86(9): 1783-1792 https://doi.org/10.1002/(SICI)1097-0142(19991101)86:9<1783::AID-CNCR21>3.0.CO;2-N
  13. Hennekens CH, Burning JE, Manson JE, Stampfer J, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334(18): 1145-1149 https://doi.org/10.1056/NEJM199605023341801
  14. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. Incidence of cancer and mortality following T-tocopherol and $\beta$-carotene supplementation: A postintervention follow-up. JAMA 2003; 290(4): 476-485 https://doi.org/10.1001/jama.290.4.476
  15. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with T-tocopherol and $\beta$-carotene: Incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90(6): 440-446 https://doi.org/10.1093/jnci/90.6.440
  16. Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 1999; 8(10); 893-899
  17. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994; 330(15): 1029-1035 https://doi.org/10.1056/NEJM199404143301501
  18. Stram DO, Hankin JH, Wilkens LR, Park S, Henderson BE, Nomura AM, et al. Prostate cancer incidence and intake of fruits, vegetables and related micronuctrients: The multiethnic cohort study (United States). Cancer Causes Control 2006; 17(9): 1193-1207 https://doi.org/10.1007/s10552-006-0064-0
  19. Arab L, Steck-Scott S, Bowen P. Participation of lycopene and beta-carotene in carcinogenesis: Defenders, aggressors, or passive bystanders? Epidemiol Rev 2001; 23(2): 211-230 https://doi.org/10.1093/oxfordjournals.epirev.a000803
  20. Le Marchand L, Hankin JH, Kolonel LN, Wilkens LR. Vegetable and fruit consumption in relation to prostate cancer risk in Hawaii: A reevaluation of the effect of dietary betacarotene. Am J Epidemiol 1991; 133(3): 215-219 https://doi.org/10.1093/oxfordjournals.aje.a115865
  21. Hsing AW, McLaughlin JK, Schuman LM, Bjelke E, Gridley G, Wacholder S, et al. Diet, tobacco use, and fatal prostate cancer: Results from the Lutheran brotherhood cohort study. Cancer Res 1990; 50(21): 6836-6840
  22. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarker Prev 2000; 9(8): 795- 804
  23. Mangels AR, Holden JM, Beecher GR, Forman MR, Lanza E. Carotenoid content of fruits and vegetables: An evaluation of analytic data. J Am Diet Assoc 1993; 93(3): 284-296 https://doi.org/10.1016/0002-8223(93)91553-3
  24. Mannisto S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 2004; 13(1): 40-48 https://doi.org/10.1158/1055-9965.EPI-038-3
  25. Deeks J, Altman DG, Bradburn MJ. Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-analysis. In: Egger M, Smith DG, Altman DG, editors. Systematic Reviews in Health Care. 2nd ed. London: BMJ Books; 2007. p. 285-312
  26. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-1558 https://doi.org/10.1002/sim.1186
  27. Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique. J Clin Epidemiol 1991; 44(2): 127-139 https://doi.org/10.1016/0895-4356(91)90261-7
  28. Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989; 81(2): 107-115 https://doi.org/10.1093/jnci/81.2.107
  29. The Cochrane Collaboration. Review Manager, version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre; 2003
  30. Stata Corporation. Stata Statistical Software. Special Edition. 8.2 for Windows. Texas: Stata Corporation; 2004
  31. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989; 64(3): 598-604 https://doi.org/10.1002/1097-0142(19890801)64:3<598::AID-CNCR2820640306>3.0.CO;2-6
  32. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995; 87(23): 1767-1776 https://doi.org/10.1093/jnci/87.23.1767
  33. Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, et al. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 2007; 99(15): 1200-1209 https://doi.org/10.1093/jnci/djm065
  34. Jain MG, Hislop GT, Howe GR, Ghadirian P. Plant foods, antioxidants, and prostate cancer risk: Findings from case-control studies in Canada. Nutr Cancer 1999; 34(2): 173-184 https://doi.org/10.1207/S15327914NC3402_8
  35. Bossetti C, Micelotta S, Dal Maso L, Talamini R, Montella M, Negri E, et al. Food groups and risk of prostate cancer in Italy. Int J Cancer 2004; 110(3): 424-428 https://doi.org/10.1002/ijc.20142
  36. Key TJ, Silcocks PB, Davey GK, Appleby PN, Biship DT. A case-control study of diet and prostate cancer. Br J Cancer 1997; 76(5): 678- 687 https://doi.org/10.1038/bjc.1997.445
  37. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 2000; 92(1): 61-68 https://doi.org/10.1093/jnci/92.1.61
  38. Jian L, Du CJ, Lee AH, Binns CW. Do dietary lycopene and other carotenoids protect against prostate cancer? Int J Cancer 2005; 113(6): 1010-1014 https://doi.org/10.1002/ijc.20667
  39. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA. Vegetable and fruit consumption and prostate cancer risk: A cohort study in the Netherlands. Cancer Epidemiol Biomarkers Prev 1998; 7(8): 673-680
  40. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003; 327(7414): 557-560 https://doi.org/10.1136/bmj.327.7414.557
  41. World Health Organization. National cancer control programmes. Policies and managerial guidelines. 2nd ed. Geneva: WHO; 2002. p.17-22
  42. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000; 283(15): 2008-2012 https://doi.org/10.1001/jama.283.15.2008
  43. Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement. Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006; 174(5): 605-614 https://doi.org/10.1164/rccm.200602-197ST
  44. Felson DT. Bias in meta-analytic research. J Clin Epidemiol 1992; 45(8): 885-892 https://doi.org/10.1016/0895-4356(92)90072-U
  45. Close DR, Kristal AR, Li S, Patterson RE, White E. Associations of demographic and health-related characteristics with prostate cancer screening in Washington state. Cancer Epidemiol Biomarkers Prev 1998; 7(7): 627-630
  46. Kolonel LN. Nutrition and prostate cancer. Cancer Causes Control 1996; 7(1): 83-94 https://doi.org/10.1007/BF00115640
  47. Giovannucci E, Rimm EB, Wolk A, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998; 58(3): 442-447
  48. Silalahi J. Anticancer and health protective properties of citrus fruit components. Asia Pac J Clin Nutr 2002; 11(1): 79-84 https://doi.org/10.1046/j.1440-6047.2002.00271.x
  49. Manthey JA, Guthrie N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem 2002; 50(21): 5837-5843 https://doi.org/10.1021/jf020121d
  50. Fan K, Kurihara N, Abe S, Ho CT, Ghai G, Yang K. Chemopreventive effects of orange peel extract (OPE). I: OPE inhibits intestinal tumor growth in ApcMin/+ mice. J Med Food 2007; 10(1): 11-17 https://doi.org/10.1089/jmf.2006.0214
  51. Coffey DS. New insights and methodologies are needed to solve the many epidemiologic enigmas of prostate cancer. Epidemiol Rev 2001; 23(1): 1 https://doi.org/10.1093/oxfordjournals.epirev.a000772
  52. Anello C, Fleiss JL. Exploratory or analytic meta-analysis: Should we distinguish between them? J Clin Epidemiol 1995; 48(1): 109-116 https://doi.org/10.1016/0895-4356(94)00084-4
  53. Choi YJ, Yoon SJ, Kim CY, Shin YS. Measuring the burden of major cancers in Korea using health life-year (HeaLY). Korean J Prev Med 2001; 34(4): 372-378. (Korean)
  54. Yoon SJ, Kwon YD, Kim BY. Estimating the disability weight of major cancers in Korea using Delphi method. Korean J Prev Med 2000; 33(4): 409-414. (Korean)